Investigation of Signals and Transcription Factors for The Generation of Female Germ-Like Cells.
Cell Differentiation
Germ Cells
Transcription factors
Journal
Cell journal
ISSN: 2228-5806
Titre abrégé: Cell J
Pays: Iran
ID NLM: 101566618
Informations de publication
Date de publication:
28 Aug 2022
28 Aug 2022
Historique:
received:
11
10
2021
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
epublish
Résumé
<strong>Objective:</strong> Primordial germ cell (PGCs) lines are a source of a highly specialized type of cells, characteristically oocytes,<br />during female germline development in vivo. The oocyte growth begins in the transition from the primary follicle. It is<br />associated with dynamic changes in gene expression, but the gene-regulating signals and transcription factors that control oocyte growth remain unknown. We aim to investigate the differentiation potential of mouse bone marrow mesenchymal stem cells (mMSCs) into female germ-like cells by testing several signals and transcription factors.<br /><strong>Materials and Methods:</strong> In this experimental study, mMSCs were extracted from mice femur bone using the flushing<br />technique. The cluster-differentiation (CD) of superficial mesenchymal markers was determined with flow cytometric analysis. We applied a set of transcription factors including retinoic acid (RA), titanium nanotubes (TNTs), and fibrin such as TNT-coated fibrin (F+TNT) formation and (RA+F+TNT) induction, and investigated the changes in gene, MVH/ DDX4, expression and functional screening using an in vitro mouse oocyte development condition. Germ cell markers expression, (MVH / DDX4), was analyzed with Immunocytochemistry staining, quantitative transcription-polymerase chain reaction (RT-qPCR) analysis, and Western blots.<br /><strong>Results:</strong> The expression of CD was confirmed by flow cytometry. The phase determination of the TNTs and F+TNT were confirmed using x-ray diffraction (XRD) and scanning electron microscope (SEM), respectively. Remarkably, applying these transcription factors quickly induced pluripotent stem cells into oocyte-like cells that were sufficient to generate female germlike cells, growth, and maturation from mMSCs differentiation. These transcription factors formed oocyte-like cells specification of stem cells, epigenetic reprogramming, or meiosis and indicate that oocyte meiosis initiation and oocyte growth are not separable from the previous epigenetic reprogramming in stem cells in vitro.<br /><strong>Conclusion:</strong> Results suggested several transcription factors may apply for arranging oocyte-like cell growth and supplies an alternative source of in vitro maturation (IVM).
Identifiants
pubmed: 36093805
doi: 10.22074/cellj.2022.8303
pmc: PMC9468721
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
458-464Références
Stem Cell Reports. 2016 Jul 12;7(1):80-94
pubmed: 27346680
J Assist Reprod Genet. 1997 Jul;14(6):337-42
pubmed: 9226513
Biol Reprod. 2004 Mar;70(3):687-93
pubmed: 14613895
Adv Mater. 2015 Dec 2;27(45):7261-84
pubmed: 26459239
Biol Reprod. 2008 Jul;79(1):35-42
pubmed: 18322276
Dev Growth Differ. 2015 Jun;57(5):378-388
pubmed: 26041547
Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:748-754
pubmed: 28532088
Biol Reprod. 2008 Mar;78(3):537-45
pubmed: 18032419
Int J Nanomedicine. 2012;7:1259-74
pubmed: 22419873
J R Soc Interface. 2009 Jan 6;6(30):1-10
pubmed: 18801715
Nature. 2005 Oct 13;437(7061):1048-52
pubmed: 16127448
Wiley Interdiscip Rev Dev Biol. 2018 Jan;7(1):
pubmed: 28892263
Semin Reprod Med. 2005 Aug;23(3):234-41
pubmed: 16059829
Development. 2008 Apr;135(8):1415-25
pubmed: 18321981
Mech Dev. 2004 Oct;121(10):1275-87
pubmed: 15327787
Cell Cycle. 2008 Mar 1;7(5):656-64
pubmed: 18256537
Int J Nanomedicine. 2013;8:3619-30
pubmed: 24101871
Biomed Res Int. 2013;2013:608728
pubmed: 23509752
Biomaterials. 2009 Oct;30(29):5319-29
pubmed: 19589591
Nanoscale. 2016 Jun 7;8(21):10963-73
pubmed: 27228212
Development. 2002 Mar;129(5):1155-64
pubmed: 11874911
Mol Cell Endocrinol. 2005 Apr 29;234(1-2):19-25
pubmed: 15836949
Int J Nanomedicine. 2017 Jul 12;12:4937-4961
pubmed: 28761338
Biomed Res Int. 2014;2014:507234
pubmed: 24826378
Fertil Steril. 2010 Dec;94(7):2507-13
pubmed: 20378111
Tissue Eng Part A. 2009 Jul;15(7):1865-76
pubmed: 19309239
Int J Nanomedicine. 2017 Jan 06;12:347-361
pubmed: 28123295
Nanomedicine (Lond). 2008 Aug;3(4):567-78
pubmed: 18694318
Dev Biol. 2006 Jan 1;289(1):115-26
pubmed: 16325797
Science. 2003 May 23;300(5623):1251-6
pubmed: 12730498
Cell Reprogram. 2017 Feb;19(1):44-53
pubmed: 28112985
Acta Biomater. 2020 Nov;117:60-76
pubmed: 32949823
Mol Endocrinol. 2007 Sep;21(9):2037-55
pubmed: 17536005
ACS Nano. 2015 Mar 24;9(3):3169-77
pubmed: 25715979
Biol Reprod. 1994 May;50(5):1100-7
pubmed: 8025167
Hum Reprod Update. 2002 Jan-Feb;8(1):21-41
pubmed: 11866238